| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Clinical Use of Recombinant FVIIa (rFVIIa)
|
Hedner, Ulla
|
|
1998
|
19 |
2 |
p. 163-176
14 p.
|
article
|
| 2 |
Computer Assisted Prospective Review of Blood Product Utilization: A Large Hospital Experience
|
Silva, Victor A
|
|
1998
|
19 |
2 |
p. 121-127
7 p.
|
article
|
| 3 |
Editorial
|
|
|
1998
|
19 |
2 |
p. 137-138
2 p.
|
article
|
| 4 |
Editorial
|
|
|
1998
|
19 |
2 |
p. 109-
1 p.
|
article
|
| 5 |
International Forum Consensus Conference on Platelet Transfusion. Final Statement
|
Contreras, Marcela
|
|
1998
|
19 |
2 |
p. 111-114
4 p.
|
article
|
| 6 |
International Forum Hepatitis C Virus RNA Testing by Nested PCR in Blood Preparations in Yugoslavia
|
Alavantic, Dragan
|
|
1998
|
19 |
2 |
p. 115-117
3 p.
|
article
|
| 7 |
Mammalian Recombinant Coagulation Proteins: Structure and Function
|
White, II, Gilbert C
|
|
1998
|
19 |
2 |
p. 177-189
13 p.
|
article
|
| 8 |
Patent report
|
|
|
1998
|
19 |
2 |
p. I-VII
nvt p.
|
article
|
| 9 |
Plasmapheresis in Myasthenia Gravis. 1 1 This paper has been presented at a symposium on behalf of the 20th anniversary of the Red Cross Blood Bank “Zuid-West Nederland” (head: dr J.Ph.H.B. Sybesma) on November 27th 1997. A survey
|
Kuks, J.B.M
|
|
1998
|
19 |
2 |
p. 129-136
8 p.
|
article
|
| 10 |
Stem Cells: What’s Happening? Focus on Quality Assurance, GMP and Regulatory Aspects
|
Seghatchian, M.J.
|
|
1998
|
19 |
2 |
p. 191-192
2 p.
|
article
|
| 11 |
Surveillance for Factor VIII Inhibitor Development in the Canadian Hemophilia A Population Following the Widespread Introduction of Recombinant Factor VIII Replacement Therapy
|
Giles, A.R
|
|
1998
|
19 |
2 |
p. 139-148
10 p.
|
article
|
| 12 |
The blood bank and hepatitis G
|
Araújo, Fernando
|
|
1998
|
19 |
2 |
p. 119-120
2 p.
|
article
|
| 13 |
Therapeutic Cytokine Stimulation of Thrombocytopoiesis
|
Harker, Laurence A.
|
|
1998
|
19 |
2 |
p. 149-162
14 p.
|
article
|
Journal description